China's Weak Supply Chain - Stops Sale of Certain Drugs
By Stephen Slade on Apr 17, 2012
The Wall Street Journal today reports China pulled 13 drugs off the market due to capsules with excessive levels of chromium. The suspect capsules were purchased from several small manufacturers in the Chinese Zhejiang province. This action begs the question: Do US Pharmaceutical companies buy packaging from these or similar firms for 'better-pricing". What assurances do consumers in advanced countries have knowing that the food they consume and the drugs they take are safe?
Food and drug supply chain safety remain major concerns for China. This is not the first time we've heard this story. Recent examples include lead-based paint in children’s toys, animal foods, baby formulas and more. Oversight in China is a real problem as manufacturers either ignore or pay little attention to consumer safety. As pharmaceutical manufacturers face increased price pressures, they will turn to lower cost alternatives. For this and other reasons, business is very cautious about moving products to untested or un-trusted markets.
Oracle offers products to help drug firms secure their distribution and supply chain with Oracle Pedigree and Serialization Manager (OPSM)
Source: Wall Street Journal, Apr 17, 2012, pg A8 by Laurie Burkitt
OPSM Product Webcast: http://www.oracle.com/ocom/groups/public/@ocom/documents/webcontent/281442.html